PTI-3

In today's world, PTI-3 has become a topic of great importance and debate. The relevance of PTI-3 has transcended different areas, from science to popular culture, generating conflicting opinions and triggering endless discussions. The importance of understanding and addressing PTI-3 comprehensively is fundamental, since its implications not only impact at the individual level, but also have repercussions at the collective level. In this article, we will explore various perspectives on PTI-3, analyzing its meaning, implications, and how it has shaped our current society.
PTI-3
Legal status
Legal status
Identifiers
  • N-({2--1,3-thiazol-4-yl}methyl)-2-methoxy-N-methylethanamine
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H28FN3OS
Molar mass389.53 g·mol−1
3D model (JSmol)
  • COCCN(C)Cc1csc(n1)c1cn(CCCCCF)c2ccccc21
  • InChI=1S/C21H28FN3OS/c1-24(12-13-26-2)14-17-16-27-21(23-17)19-15-25(11-7-3-6-10-22)20-9-5-4-8-18(19)20/h4-5,8-9,15-16H,3,6-7,10-14H2,1-2H3
  • Key:LXQIIHJBHSFWQW-UHFFFAOYSA-N

PTI-3 is an indole-3-thiazole based synthetic cannabinoid which has been sold as a designer drug. It was first identified in Hungary in 2020, and was made illegal in Italy in June 2021.

See also


References

  1. ^ Malaca S, Tini A, Umani Ronchi F (January 2022). "Fourth generation of synthetic cannabinoid receptor agonists: a summary on the latest insights". Acta Bio-Medica. 92 (6): e2021546. doi:10.23750/abm.v92i6.12696. PMC 8823589. PMID 35075053.
  2. ^ European Monitoring Center for Drugs and Drug Addiction (December 2020). New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. An update from the EU Early Warning System (PDF). Luxembourg: Publications Office of the European Union. doi:10.2810/921262. ISBN 9789294975584.
  3. ^ "Decreto 1 Giugno 2021. Aggiornamento delle tabelle contenenti l'indicazione delle sostanze stupefacenti e psicotrope, di cui al decreto del Presidente della Repubblica 9 ottobre 1990, n. 309 e successive modificazioni e integrazioni. Inserimento nella tabella I di nuove sostanze psicoattive. (21A03590) (GU Serie Generale n.144 del 18-06-2021)" [Decree of 1 June 2021. Update of the tables containing the indication of narcotic and psychotropic substances, as per the decree of the President of the Republic of 9 October 1990, n. 309 and subsequent amendments and additions. Inclusion in Table I of new psychoactive substances. (21A03590) (GU General Series n.144 of 18-06-2021] (in Italian).